Aura Biosciences, Inc. (AURA) Tops Q3 EPS by 6c

Aura Biosciences, Inc. (NASDAQ: AURA) reported Q3 EPS of ($0.40), $0.06 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.

You May Also Be Interested In

• SpaceX (SPCX) gains nearly 6% as traders follow the money
• Dynatrace Is Said to Offer Zero Coupon on Exchangeable Bond
• The OLB Group Reports Second Quarter 2026 Results and Completes Company-Wide Transition to AI-Assisted Software Development